H.C. Wainwright Initiates Coverage On Calithera Biosciences with Buy Rating, Announces $7 Price Target

H.C. Wainwright initiates coverage on Calithera Biosciences (NASDAQ:CALA) with a Buy rating and a $7 price target.

Benzinga · 11/19/2019 12:48

H.C. Wainwright initiates coverage on Calithera Biosciences (NASDAQ:CALA) with a Buy rating and a $7 price target.